Key Financial Data Of Group

Kringle Pharma,Inc. - Filing #7609492

Concept 2022-01-01 to
2022-03-31
2021-10-01 to
2022-03-31
As at
2022-03-31
2020-10-01 to
2021-09-30
As at
2021-09-30
2020-10-01 to
2021-03-31
2021-01-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
27,300,000 JPY
289,756,000 JPY
117,825,000 JPY
Ordinary profit (loss)
-318,965,000 JPY
-299,676,000 JPY
-191,777,000 JPY
Net assets
2,581,572,000 JPY
2,506,149,000 JPY
2,611,199,000 JPY
Total assets
2,909,958,000 JPY
2,635,625,000 JPY
2,753,574,000 JPY
Basic earnings (loss) per share
-40.18
-70.24
-72.51
-48.33
-30.32
Diluted earnings per share
Equity-to-asset ratio
0.887 xbrli:pure
0.951 xbrli:pure
0.948 xbrli:pure
Net cash provided by (used in) operating activities
-158,632,000 JPY
-560,922,000 JPY
-268,903,000 JPY
Net cash provided by (used in) investing activities
-254,374,000 JPY
JPY
JPY
Net cash provided by (used in) financing activities
394,652,000 JPY
595,904,000 JPY
597,026,000 JPY
Cash and cash equivalents
2,119,165,000 JPY
2,137,520,000 JPY
2,430,662,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.